期刊文献+

心脏移植手术的围手术期处理 被引量:1

The Management of Cardiac Transplantation in Peri-operative Period
下载PDF
导出
摘要 目的:总结心脏移植围手术期处理的初步经验。方法:2例终末期扩张性心肌病和1例复杂性先心病人进行了同种原位心脏移植术,围手术期分别在受体和供体的选择、供心的保护、循环和呼吸的支持治疗、免疫治疗和监测、预防感染这五方面着重进行了处理。结果:所有病人均存活,心功能由Ⅳ级提升至Ⅰ~Ⅱ级;术前EF平均27.67%,术后提高到69.3%;未发生循环和呼吸系统并发症,亦未发生排异和严重感染等并发症,顺利出院。随访1年多,3例患者均生活质量良好。结论:心脏移植手术的成功除了熟练的手术技术外,选择恰当的供体和受体、良好的供心保护、适当的循环和呼吸的支持治疗、正确的免疫治疗和监测、有效的防感染措施是心脏移植围手术期处理的重点,是确保手术成功的关键。 Objective: To sum up the experience of perioperative management of orthotopic cardiac transplantation. Methods : Othotopic heart transplantations were performed on two cases of terminal myocardosis and one case of congenital tricuspid atresia. During intraoperative period, meticulous attention was paid on selection of recipient and donor, protection of donor heart: circulatory and respiratory support: administration of immunosuppressive drugs and monitoring of rejection, prevention of infection. Results: All patients survived and discharged uneventfully. Rejection and infection didnot occur. Heart function improved from NYHA classc! preoperatively to NYHA class `! - a! postoperatively. LVEF improved from 27.67% preopera-tively to 69.30% postoperatively. Following up for one year, all patients had a good quality of life. Conclusion: Appropriate perioperative management including patient selection, donor heart protection, circulation and respiration support, immunosuppressive therapy and monitoring of rejection, prevention of infection are critical for successful heart transplantation.
出处 《中国临床医学》 2002年第6期679-681,共3页 Chinese Journal of Clinical Medicine
关键词 心脏移植 围手术期 受体 供体 心肌保护 抗感染 Heart transplantation Intraoperative period
  • 相关文献

参考文献9

  • 1Rodeheffer RJ, McGregor CG. The development of cardiac transplantation. Mayo Clin Proc. 1992,67(5): 480~484.
  • 2Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and risk of heart transplantation. J Heart Transplantation, 1988, 7:331~336.
  • 3Yung JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient. J Heart Lung Transplant.1994, 13(3)353~364.
  • 4Jahania MS, Sanchez JA, Narayan P, et al. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg,1999, 68(5): 1983~1987
  • 5Aleksic I, Baryalei M, Busch T, et al. Improvement of impaired renal function in heart transplant recipients with myocophenolate mofetil and low- dose cyclosporine. Transplantation, 2000, 27;69(8): 1586~1569.
  • 6Meiser BM, Uberfuhr P, et al. Single - center randomized trial comparing tacrolimus(FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant, 1998,17(8): 782~788.
  • 7Reichart B, Meiser B. European multicenter tacrolimus(FK506)heart pilot study: one- year results- European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant, 1998, 17(8): 775~781.
  • 8Smart FW, Naftel DC, Costanzo MR, et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant, 1996,15(4) :329~341.
  • 9Miller,LW, Natel DC, Bourge RE, et al. Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant, 1994, 13(3): 381~392.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部